Open Access
Volume 8, Number 2, June 2018
Article Number 9
Number of page(s) 6
Published online 28 May 2018
  1. Pascual D, Borque A. Epidemiology of kidney cancer. Adv Urol. 2008; 2008: 782381. [Google Scholar]
  2. Mohammadian M, Pakzad R, Towhidi F, Makhsosi BR, Ahmadi A, Salehiniya H. Incidence and mortality of kidney cancer and its relationship with HDI (Human Development Index) in the world in 2012. Clujul Med. 2017; 90(3): 286-93. [PubMed] [Google Scholar]
  3. Lindblad P. Epidemiology of renal cell carcinoma. Scand J Surg. 2004; 93(2): 88-96. [CrossRef] [PubMed] [Google Scholar]
  4. Adibi M, Karam JA, Wood CG. Reporting geographic and temporal trends in renal cell carcinoma: why is this important? Eur urol. 2015; 67(3): 531-2. [Google Scholar]
  5. Basiri A, Shakhssalim N, Jalaly NY, Miri HH, Partovipour E, Panahi MH. Difference in the incidences of the most prevalent urologic cancers from 2003 to 2009 in Iran. Asian Pac J Cancer Prev. 2014; 15(3): 1459-63. [CrossRef] [PubMed] [Google Scholar]
  6. Masoompour SM, Lankarani KB, Honarvar B, Tabatabaee SH, Moghadami M, Khosravizadegan Z. Changing Epidemiology of Common Cancers in Southern Iran, 2007-2010: A Cross Sectional Study. PLoS One. 2016; 11(5): e0155669. [Google Scholar]
  7. Habibi A. Epidemiological aspects of cancer in Iran. Int Surg. 1985; 70(2): 105-8. [PubMed] [Google Scholar]
  8. Etemadi A, Sadjadi A, Semnani S, Nouraie SM, Khademi H, Bahadori M. Cancer registry in Iran: a brief overview. Arch Iran Med. 2008; 11(5): 577-80. [PubMed] [Google Scholar]
  9. Rezaianzadeh A, Azgomi SH, Mokhtari AM, Maghsoudi A, Nazarzadeh M, Dehghani SL, et al. The Incidence of Breast Cancer in Iran: A Systematic Review and Meta-Analysis. J Anal Oncol. 2016; 5(4): 139-45. [CrossRef] [Google Scholar]
  10. Rezaianzadeh A, Jalali M, Maghsoudi A, Mokhtari AM, Azgomi SH, Dehghani SL. The overall 5-year survival rate of breast cancer among iranian women: A systematic review and meta-analysis of published studies. Breast Dis. 2017(Preprint): 1-6. [PubMed] [Google Scholar]
  11. Deshpande S, van Asselt A, Tomini F, Armstrong N, Allen A, Noake C, et al. Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) checklist. 2013. [Google Scholar]
  12. Mehrabani D, Tabei SZ, Heydari ST, Shamsina SJ, Shokrpour N, Amini M, et al. Cancer Occurrence in Fars Province, Southern Iran. Iran Red Crescent Med J. 2008; 10(4): 314-22. [Google Scholar]
  13. Masoompour SM, Yarmohammadi H, Rezaianzadeh A, Lankarani KB. Cancer incidence in southern Iran, 1998-2002: results of population-based cancer registry. Cancer Epidemiol. 2011; 35(5): e42-7. [Google Scholar]
  14. Sadjadi A, Malekzadeh R, Derakhshan MH, Sepehr A, Nouraie M, Sotoudeh M, et al. Cancer occurrence in Ardabil: results of a population-based cancer registry from Iran. Int J Cancer. 2003; 107(1): 113-8. [CrossRef] [PubMed] [Google Scholar]
  15. Babaei M, Jaafarzadeh H, Sadjadi AR, Samadi F, Yazdanbod A, Fallah M, et al. Cancer Incidence and Mortality in Ardabil: Report of an Ongoing Population-Based Cancer Registry in Iran, 2004-2006. Iran J Public Health. 2009; 38(4): 35-45. [Google Scholar]
  16. Sadiadi A, Zahedi MJ, Moghadam SD, Nouraie M, Alimohammadian M, Ghorbani A, et al. The first population-based cancer survey in Kerman Province of Iran. Iran J Public Health. 2007; 36(4): 26-34. [Google Scholar]
  17. Babai M, Mousavi S, Malek M, Danaie N, Jandaghi J, Tousi J, et al. Survey of cancer incidence during a 5-year (1998-2002) period in Semnan province. Koomesh. 2005; 6(3): 237-44. [Google Scholar]
  18. Somi MH, Farhang S, Mirinezhad SK, Naghashi S, Seif-Farshad M, Golzari M. Cancer in East Azerbaijan, Iran: results of a populationbased cancer registry. Asian Pac J Cancer Prev. 2008; 9(2): 327-30. [PubMed] [Google Scholar]
  19. Mohagheghi MA, Mosavi-Jarrahi A, Malekzadeh R, Parkin M. Cancer incidence in Tehran metropolis: the first report from the Tehran Population-based Cancer Registry, 1998-2001. Arch Iran Med. 2009; 12(1): 15-23. [PubMed] [Google Scholar]
  20. Fateh M, Emamian MH. Cancer incidence and trend analysis in shahroud, iran, 2000-2010. Iran J Cancer Prev. 2013; 6(2): 85-94. [PubMed] [Google Scholar]
  21. Mousavi SM, Gouya MM, Ramazani R, Davanlou M, Hajsadeghi N, Seddighi Z. Cancer incidence and mortality in Iran. Ann Oncol. 2009; 20(3): 556-63. [CrossRef] [PubMed] [Google Scholar]
  22. Roshandel G, Boreiri M, Sadjadi A, Malekzadeh R. A diversity of cancer incidence and mortality in West Asian populations. Ann Glob Health. 2014; 80(5): 346-57. [CrossRef] [PubMed] [Google Scholar]
  23. Mirzaei M, Pournamdar Z, Salehiniya H. Epidemiology and Trends in Incidence of Kidney Cancer in Iran. Asian Pac J Cancer Prev. 2015; 16(14): 5859-61. [CrossRef] [PubMed] [Google Scholar]
  24. Arabsalmani M, Mohammadian-Hafshejani A, Ghoncheh M, Hadadian F, Towhidi F, Vafaee K, et al. Incidence and mortality of kidney cancers, and human development index in Asia; a matter of concern. J Nephropathol. 2017; 6(1): 30-42. [CrossRef] [Google Scholar]
  25. Aghaei Meybodi HR, Khashayar P, Rezai Homami M, Heshmat R, Larijani B. Prevalence of hypertension in an Iranian population. Ren Fail. 2014; 36(1): 87-91. [CrossRef] [PubMed] [Google Scholar]
  26. Moosazadeh M, Ziaaddini H, Mirzazadeh A, Ashrafi-Asgarabad A, Haghdoost AA. Meta-analysis of Smoking Prevalence in Iran. Addict Health. 2013; 5(3-4): 140-53. [PubMed] [Google Scholar]
  27. Meysamie A, Ghaletaki R, Zhand N, Abbasi M. Cigarette smoking in iran. Iran J Public Health. 2012; 41(2): 1-14. [Google Scholar]
  28. Tavakkoli L, Khanjani N. Environmental and occupational exposure to cadmium in Iran: a systematic review. Rev Environ Health. 2016; 31(4): 457-63. [CrossRef] [PubMed] [Google Scholar]
  29. Malekmakan L, Pakfetrat M, Daneshian A, Sayadi M. A Comparison of Socioeconomic Level among Hemodialysis Patients and Normal Controls in the Fars Province, Iran. SJKDT. 2017; 28(5): 1138-43. [Google Scholar]
  30. Stojanovic M, Goldner B, Ivkovic D. Renal cell carcinoma and arterial hypertension. Clin Exp Nephrol. 2009; 13(4): 295-9. [CrossRef] [PubMed] [Google Scholar]
  31. Chow WH, Gridley G, Fraumeni JF, Jr., Jarvholm B. Obesity, hypertension, and the risk of kidney cancer in men. N Engl J Med. 2000; 343(18): 1305-11. [CrossRef] [PubMed] [Google Scholar]
  32. Keramatinia A, Hassanipour S, Nazarzadeh M, Wurtz M, Monfared AB, Khayyamzadeh M, et al. Correlation between nitrogen dioxide as an air pollution indicator and breast cancer: a systematic review and meta-analysis. Asian Pac J Cancer Prev. 2016; 17(1): 419-24. [CrossRef] [PubMed] [Google Scholar]
  33. Keyghobadi N, Rafiemanesh H, Mohammadian-Hafshejani A, Enayatrad M, Salehiniya H. Epidemiology and trend of cancers in the province of Kerman: southeast of Iran. Asian Pac J Cancer Prev. 2015; 16(4): 1409-13. [CrossRef] [PubMed] [Google Scholar]
  34. Sadjadi A, Zahedi M, Nouraie M, Alimohammadian M, Ghorbani A, Bahmanyar S, et al. The first population-based cancer survey in Kerman Province of Iran. Iran J Public Health. 2007; 36(4): 26-34. [Google Scholar]
  35. Hassanipour-Azgomi S, Mohammadian-Hafshejani A, Ghoncheh M, Towhidi F, Jamehshorani S, Salehiniya H. Incidence and mortality of prostate cancer and their relationship with the Human Development Index worldwide. Prostate Int. 2016; 4(3): 118-24. [CrossRef] [PubMed] [Google Scholar]
  36. Hassanipour S, Mohammadian-Hafshejani A, Ghoncheh M, Salehiniya H. The incidence and mortality of esophageal cancer and its relationship with development in the world. Biomed Res Ther. 2017; 4(9): 1607-23. [CrossRef] [Google Scholar]